TY - JOUR
T1 - Defective expression of T cell antigens in chronic lymphocytic leukaemia
T2 - relationship to T cell dysfunction
AU - Kay, Neil E.
AU - Kaplan, Manuel E.
PY - 1984/5
Y1 - 1984/5
N2 - Summary. In chronic lymphocytic leukaemia (CLL) peripheral blood T cells have a variety of functional abnormalities. To explore more extensively the T cell status of B‐CLL patients, surface immunoglobulin‐negative cells were isolated by sheep erythrocyte rosetting (ER) and the membrane phenotypes of the ER + cells defined by immunofluorescence utilizing monoclonal antibodies (MAb). In 11 of 18 CLL patients (CLL group I) there was excellent correlation between ER + and T3 (mature T cell marker) positivity. In the remaining patients (CLL group II), only 5–45% of ER+ cells were T3 positive, suggesting that many rosetting cells were non‐T, However, the ER+, T3 negative cells were nonreactive with OKM‐1 (MAb which detects monocytes and ‘null’ lymphocytes) or with OKT11, 9.6, and 35.1, MAb against the T cell E receptor. Moreover ER +, T3 negative cells were not stained with OKT4, OKT8, OKT6, OKT9, or OKT10. Treatment of group II ER + cells with neuraminidase increased (from 27% to 74%) the mean percentages of T3 positive cells detected, but not other membrane antigens. ER+ cells from group II patients, compared with normal and group I patients, exhibited diminished proliferative responses to PHA and Con‐A (P<0.01) and supported poorly pokeweed mitogeninduced proliferation of normal allogeneic B cells (P<0.01). Thus, in approximately one‐third of the CLL patients studied, many ER+ cells poorly express a number of membrane antigens characteristic of normal mature T cells, one of which (T3) is unmasked by neuraminidase treatment. This phenotypic abnormality appears to be associated with significant T cell dysfunction in vitro and may, at least in part, contribute to the commonly encountered immunological defects present in these patients.
AB - Summary. In chronic lymphocytic leukaemia (CLL) peripheral blood T cells have a variety of functional abnormalities. To explore more extensively the T cell status of B‐CLL patients, surface immunoglobulin‐negative cells were isolated by sheep erythrocyte rosetting (ER) and the membrane phenotypes of the ER + cells defined by immunofluorescence utilizing monoclonal antibodies (MAb). In 11 of 18 CLL patients (CLL group I) there was excellent correlation between ER + and T3 (mature T cell marker) positivity. In the remaining patients (CLL group II), only 5–45% of ER+ cells were T3 positive, suggesting that many rosetting cells were non‐T, However, the ER+, T3 negative cells were nonreactive with OKM‐1 (MAb which detects monocytes and ‘null’ lymphocytes) or with OKT11, 9.6, and 35.1, MAb against the T cell E receptor. Moreover ER +, T3 negative cells were not stained with OKT4, OKT8, OKT6, OKT9, or OKT10. Treatment of group II ER + cells with neuraminidase increased (from 27% to 74%) the mean percentages of T3 positive cells detected, but not other membrane antigens. ER+ cells from group II patients, compared with normal and group I patients, exhibited diminished proliferative responses to PHA and Con‐A (P<0.01) and supported poorly pokeweed mitogeninduced proliferation of normal allogeneic B cells (P<0.01). Thus, in approximately one‐third of the CLL patients studied, many ER+ cells poorly express a number of membrane antigens characteristic of normal mature T cells, one of which (T3) is unmasked by neuraminidase treatment. This phenotypic abnormality appears to be associated with significant T cell dysfunction in vitro and may, at least in part, contribute to the commonly encountered immunological defects present in these patients.
UR - http://www.scopus.com/inward/record.url?scp=0021273943&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021273943&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.1984.tb02870.x
DO - 10.1111/j.1365-2141.1984.tb02870.x
M3 - Article
C2 - 6609711
AN - SCOPUS:0021273943
SN - 0007-1048
VL - 57
SP - 105
EP - 111
JO - British journal of haematology
JF - British journal of haematology
IS - 1
ER -